483 related articles for article (PubMed ID: 31962287)
1. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I
Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676
[TBL] [Abstract][Full Text] [Related]
4. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.
Morena M; Berardi A; Colucci P; Palmery M; Trezza V; Hill MN; Campolongo P
Neuropsychopharmacology; 2018 May; 43(6):1284-1296. PubMed ID: 29265107
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
Zer-Aviv TM; Akirav I
Hippocampus; 2016 Jul; 26(7):947-57. PubMed ID: 26928784
[TBL] [Abstract][Full Text] [Related]
7. The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.
Rea K; McGowan F; Corcoran L; Roche M; Finn DP
Br J Pharmacol; 2019 May; 176(10):1492-1505. PubMed ID: 29847859
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
Ganon-Elazar E; Akirav I
Neuropsychopharmacology; 2012 Jan; 37(2):456-66. PubMed ID: 21918506
[TBL] [Abstract][Full Text] [Related]
9. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
Segev A; Rubin AS; Abush H; Richter-Levin G; Akirav I
Neuropsychopharmacology; 2014 Mar; 39(4):919-33. PubMed ID: 24141570
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats.
Simone JJ; Baumbach JL; McCormick CM
Int J Dev Neurosci; 2018 Oct; 69():119-131. PubMed ID: 30063953
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.
Burstein O; Shoshan N; Doron R; Akirav I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):129-139. PubMed ID: 29458190
[TBL] [Abstract][Full Text] [Related]
13. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
14. Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear.
Bisby MA; Richardson R; Baker KD
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109834. PubMed ID: 31830508
[TBL] [Abstract][Full Text] [Related]
15. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
Hasanein P; Teimuri Far M
Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
[TBL] [Abstract][Full Text] [Related]
16. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.
Lisboa SF; Niraula A; Resstel LB; Guimaraes FS; Godbout JP; Sheridan JF
Neuropsychopharmacology; 2018 Aug; 43(9):1924-1933. PubMed ID: 29786066
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.
Maymon N; Mizrachi Zer-Aviv T; Sabban EL; Akirav I
Neuropharmacology; 2020 Jan; 162():107804. PubMed ID: 31622603
[TBL] [Abstract][Full Text] [Related]
18. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
19. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.
Segev A; Korem N; Mizrachi Zer-Aviv T; Abush H; Lange R; Sauber G; Hillard CJ; Akirav I
Neuropsychopharmacology; 2018 Sep; 43(10):2017-2027. PubMed ID: 29977073
[TBL] [Abstract][Full Text] [Related]
20. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
